R&D News | pharmaphorum

News

After losing ground in commercial clinical trials in recent years, the UK has now turned a corner and is once again taking a "global lead."

News

Imec will demonstrate an ingestible sensor device today that can monitor gut health and could be a valuable tool for research and clinical trials.

News

The decision by the UK to set new 10-year budgets for public R&D funding has received a positive response from academia and the pharma industry.

News

Pfizer has joined the ranks of those developing cancer drugs that target PD-1 and VEGF, penning a $6bn licensing deal with China's 3SBio.

News

The partner of disgraced ex-Theranos CEO Elizabeth Holmes, Billy Evans, has reportedly raised millions of dollars for another blood testing startup.

News

BioMarin has made its first M&A play under James Sabry, buying Inozyme to flesh out its enzyme replacement therapies (ERTs) for rare diseases.